Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 20Sarcoma 1Breast 1

Conditions

Sarcoma 39Leiomyosarcoma 10Osteosarcoma 8Breast Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Neoplasm Metastasis 4Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Chondrosarcoma 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Synovial 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Hemangiosarcoma 3Esophageal Neoplasms 3Dermatofibrosarcoma 3Colorectal Neoplasms 3Bone Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Rhabdomyosarcoma 2Recurrent Uterine Corpus Sarcoma 2Neuroblastoma 2

Interventions

Paclitaxel 3aflibercept 2Taxes 2Specimen Handling 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Gene Expression Profiling 2Fentanyl 2Cisplatin 2Carboplatin 2tinostamustine 1sodium thiosulfate 1rucaparib 1pelcitoclax 1motexafin lutetium 1entinostat 1cobimetinib 1X-Rays 1Topotecan 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Serotonin Plasma Membrane Transport Proteins 1Ropivacaine 1Radiotherapy 1Radiation 1Quality of Life 1Polymerase Chain Reaction 1Platinum 1Patient Reported Outcome Measures 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Docetaxel × Sarcoma × Clear all
NCT00287885 2017-11-29

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
18 enrolled
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡